<?xml version="1.0" encoding="UTF-8" ?>
<rss version="2.0">
    <channel>
        <title>RSS News Listing</title>
        <link>https://ki.se</link>
        <description>RSS News Listing</description>
        <item>
    <title>Blood test reveals risk of multimorbidity</title>
    <link>https://news.ki.se/blood-test-reveals-risk-of-multimorbidity</link>
    <description>A small set of common blood biomarkers predicts which older adults will develop specific combinations of chronic diseases – and how quickly, a new study from Karolinska Institutet published in Nature Medicine reports. </description>
    <pubDate>Wed, 07 Jan 2026 10:00:11 +0100</pubDate>
</item><item>
    <title>Healthy diet can slow down chronic diseases in older people</title>
    <link>https://news.ki.se/healthy-diet-can-slow-down-chronic-diseases-in-older-people</link>
    <description>A healthy diet can slow down the accumulation of chronic diseases in older adults, while inflammatory diets accelerate it. This is shown by a new study from Karolinska Institutet published in Nature Aging.</description>
    <pubDate>Mon, 28 Jul 2025 15:13:45 +0200</pubDate>
</item><item>
    <title>New genetic knowledge about cluster headache</title>
    <link>https://news.ki.se/new-genetic-knowledge-about-cluster-headache</link>
    <description>Researchers at Karolinska Institutet, together with British colleagues, have conducted the largest study to date in search of genetic markers about cluster headache. In the long term, it can hopefully pave the way for more effective treatments. The study is published in the scientific journal Annals of Neurology. </description>
    <pubDate>Wed, 14 Jul 2021 21:04:34 +0200</pubDate>
</item><item>
    <title>These lifestyle choices can reduce the risk of chronic kidney disease</title>
    <link>https://news.ki.se/these-lifestyle-choices-can-reduce-the-risk-of-chronic-kidney-disease</link>
    <description>Active lifestyle choices such as eating vegetables, exercising and quitting smoking can reduce the risk of chronic kidney disease, a new study led by researchers at Karolinska Institutet in Sweden and Griffith University in Australia, reports. The study is published in the Journal of the American Society of Nephrology. </description>
    <pubDate>Wed, 02 Sep 2020 08:38:41 +0200</pubDate>
</item><item>
    <title>Twelve-year clinical trajectories of multimorbidity in a population of older adults</title>
    <link>https://news.ki.se/twelve-year-clinical-trajectories-of-multimorbidity-in-a-population-of-older-adults</link>
    <description>Researchers at Aging Research Center, KI, and collaborators in Italy and Spain, studied how multimorbidity, the occurrence of multiple chronic diseases in the same individual, changed over time in old individuals during a 12-year period using data from the Swedish National study on Aging and Care in Kungsholmen (SNAC-K). The study is published today in the scientific journal Nature Communications. </description>
    <pubDate>Fri, 26 Jun 2020 15:27:04 +0200</pubDate>
</item><item>
    <title>Certain diabetes drugs may protect against serious kidney problems</title>
    <link>https://news.ki.se/certain-diabetes-drugs-may-protect-against-serious-kidney-problems</link>
    <description>Use of sodium glucose cotransporter 2 (SGLT2) inhibitors to treat type 2 diabetes may help to lower the risk of serious kidney problems, according to a Scandinavian study led by researchers at Karolinska Institutet. The findings, now published in the journal The BMJ, provide support for the use of SGLT2 inhibitors in a broad range of patients with type 2 diabetes, according to the researchers.</description>
    <pubDate>Thu, 30 Apr 2020 09:19:37 +0200</pubDate>
</item><item>
    <title>Possible new treatment strategy against progeria</title>
    <link>https://news.ki.se/possible-new-treatment-strategy-against-progeria</link>
    <description>Progeria is a very rare disease that affects about one in 18 million children and results in premature aging and death in adolescence from complications of cardiovascular disease. In a study on mice and human cells, researchers at Karolinska Institutet and IFOM, the FIRC Institute of Molecular Oncology in Italy, have identified how antisense oligonucleotide therapies could be used as a new possible treatment option for the disease. The results are published in Nature Communications.</description>
    <pubDate>Mon, 18 Nov 2019 11:00:00 +0100</pubDate>
</item><item>
    <title>New Board of Directors for CIMED</title>
    <link>https://news.ki.se/new-board-of-directors-for-cimed</link>
    <description></description>
    <pubDate>Fri, 02 Feb 2018 11:02:35 +0100</pubDate>
</item>
    </channel>
</rss>